Cordlife Refutes Media Reports on License

MT Newswires
2025/10/21

Cordlife (SGX:P8A) provided clarifications over certain media reports regarding its cord blood banking service license matters, according to a Tuesday filing with the Singapore Exchange.

Regarding a release made by the Ministry of Health, the company said that while 160 cord blood units were collected since January this year and the ministry did not state that all were affected by process failures.

Meanwhile, the company said that while it had been granted an extension of time by the MOH from Oct. 13 to submit written representations to avoid its license getting suspended, suspension will be under consideration based on representations.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10